World News
COVID bivalent booster appears to offer added benefits against Omicron
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies show.
Read more.Flu continues hasty retreat in US; COVID, RSV markers fall
In another COVID development, the FDA pulled its EUA for Evusheld, the last available monoclonal antibody treatment, due to weak
Read more.COVID vaccine-boosted nursing home residents at 30% to 50% lower risk of infection
Residents not up to date on recommended COVID-19 vaccines were at a 30% to 50% higher risk for infection.
Read more.Rate of Americans reporting long-COVID symptoms declining
Data show the share of Americans reporting long COVID has dropped over the past 6 months, while another study suggests
Read more.FDA panel recommends move toward streamlined COVID vaccine approach
FDA advisers recommend offering just the newer bivalent versions of the vaccine for both primary and booster series.
Read more.